16 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/6/22 16:05
4/4/22
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SM.d5536.2808888D
4/6/22 16:05
4/4/22
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SS.d-1,65218.770-88-5088D
1/5/22 16:23
1/3/22
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSmith Christopher MNJDOCB,CEOM.d1,25612.56010037367D
1/5/22 16:23
1/3/22
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSmith Christopher MNJDOCB,CEOS.d-2,11021.100-100-21367D
1/5/22 16:23
1/3/22
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SM.d8166.28013088D
1/5/22 16:23
1/3/22
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SS.d-2,74221.090-130-6088D
10/19/21 16:15
10/15/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SM.d4746.2807562088D
10/19/21 16:15
10/15/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SS.d-1,48919.730-75-4688D
9/16/21 16:30
9/14/21
OCDXFinancInvAdvInvestment AdviceCarlyle Group Inc.DCTS-425,04016.800-25,300-18118,106I
8/18/21 17:41
8/16/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SM.dm2836.2804510688D
8/18/21 17:41
8/16/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SS.dm-90620.130-45-3488D
8/13/21 17:22
8/11/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SM.dm5346.28085999%88D
8/13/21 17:22
8/11/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSchlesinger Michael A.NJOEVP,GC,SS.dm-1,68319.800-85-4988D
8/4/21 18:29
8/2/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticYates Robert CliftonNJDM.d1456.280235D
8/4/21 18:29
8/2/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticYates Robert CliftonNJDS.dm-7,41821.710-342-995D
8/4/21 18:29
8/2/21
OCDXHealthDiagnIn Vitro & In Vivo DiagnosticSmith Christopher MNJDOCB,CEOS.m-5,89021.820-270-42367D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact